These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9055921

  • 1. Effect of growth hormone treatment in children with craniopharyngioma with reference to the KIGS (Kabi International Growth Study) database.
    Price DA, Jönsson P.
    Acta Paediatr Suppl; 1996 Oct; 417():83-5. PubMed ID: 9055921
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.
    Price DA, Wilton P, Jönsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB.
    Horm Res; 1998 Oct; 49(2):91-7. PubMed ID: 9485178
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [Abstract] [Full Text] [Related]

  • 5. Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort.
    Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ibáñez L, Carlsson M, Cutfield W, Rooman R, Gomez R, Wajnrajch MP, Linglart A, Stawerska R, Clayton PE, Darendeliler F, Hokken-Koelega ACS, Horikawa R, Tanaka T, Dörr HG, Albertsson-Wikland K, Polak M, Grimberg A.
    J Clin Endocrinol Metab; 2022 Nov 25; 107(12):3287-3301. PubMed ID: 36102184
    [Abstract] [Full Text] [Related]

  • 6. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database.
    Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB.
    J Clin Endocrinol Metab; 2006 Jun 25; 91(6):2047-54. PubMed ID: 16537676
    [Abstract] [Full Text] [Related]

  • 7. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr 25; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 8. Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee.
    Taback SP, Dean HJ.
    J Clin Endocrinol Metab; 1996 May 25; 81(5):1693-6. PubMed ID: 8626817
    [Abstract] [Full Text] [Related]

  • 9. Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma.
    Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M.
    J Clin Endocrinol Metab; 1995 Feb 25; 80(2):374-8. PubMed ID: 7852493
    [Abstract] [Full Text] [Related]

  • 10. Growth response in the first year of growth hormone treatment in prepubertal children with organic growth hormone deficiency: a comparison with idiopathic growth hormone deficiency. The Executive Scientific Committee of the Kabi International Growth Study.
    Price DA, Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1990 Feb 25; 370():131-7; discussion 138. PubMed ID: 2260451
    [Abstract] [Full Text] [Related]

  • 11. Reference curve for the first-year growth response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency: validation of the KIGS first-year growth response curve using the Belgian Register for the Study of Growth and Puberty Problems.
    Straetemans S, Roelants M, Thomas M, Rooman R, De Schepper J.
    Horm Res Paediatr; 2014 Feb 25; 81(5):343-9. PubMed ID: 24686034
    [Abstract] [Full Text] [Related]

  • 12. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
    Hilczer M, Smyczynska J, Stawerska R, Lewinski A.
    Neuro Endocrinol Lett; 2005 Feb 25; 26(1):19-24. PubMed ID: 15726014
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth in height compared with advancement in skeletal maturity in patients treated with human growth hormone.
    Milner RD, Preece MA, Tanner JM.
    Arch Dis Child; 1980 Jun 25; 55(6):461-6. PubMed ID: 7436485
    [Abstract] [Full Text] [Related]

  • 15. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
    Smith TR, Cote DJ, Jane JA, Laws ER.
    J Neurosurg Pediatr; 2016 Oct 25; 18(4):408-412. PubMed ID: 27286443
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A.
    Acta Paediatr Suppl; 1994 Dec 25; 406():18-23; discussion 24. PubMed ID: 7734807
    [Abstract] [Full Text] [Related]

  • 17. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
    Darendeliler F, Berberoğlu M, Ocal G, Adiyaman P, Bundak R, Günöz H, Baş F, Darcan S, Gökşen D, Arslanoğlu I, Yildiz M, Ercan O, Ercan G, Ozerkan E, Can S, Böber E, Adal E, Sarikaya S, Dallar Y, Siklar Z, Bircan I, Bideci A, Yüksel B, Büyükgebiz A.
    J Pediatr Endocrinol Metab; 2005 Oct 25; 18(10):949-54. PubMed ID: 16355808
    [Abstract] [Full Text] [Related]

  • 18. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM, Bin-Abbas BS, Kaplan SL.
    Horm Res; 1998 Oct 25; 49 Suppl 2():41-57. PubMed ID: 9730672
    [Abstract] [Full Text] [Related]

  • 19. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1991 Oct 25; 379():109-15; discussion 116. PubMed ID: 1815451
    [Abstract] [Full Text] [Related]

  • 20. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
    Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J, Turner HE, Wass JA.
    Clin Endocrinol (Oxf); 2006 May 25; 64(5):556-60. PubMed ID: 16649976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.